Sleep

In this session, Daniel Picchietti, MD, discussed changes to the diagnostic guidelines for restless legs syndrome/Willis-Ekbom disease published jointly by the International Restless Legs Syndrome Study Group and the National Institutes of Health.

In this session, Stephany Fulda, PhD, discussed the common causes of restless leg syndrome (RLS), considerations for the clinical application of treatment strategies for RLS, and changes to treatment guidelines for RLS that may be on the horizon.

Dr Thomas Roth, PhD, presented on the evolution of our understanding of insomnia, and the importance of insomnia in the context of other disease states. Roth noted that insomnia is primarily a disorder of increased wakefulness from a pathophysiologic standpoint, and presented data to support this. Presenting the effect of improved sleep on diseases such as depression, worker productivity, and cardiovascular disease, Roth revealed rich prospects for the future of sleep medicine in treating a variety of disorders.

In this video, Phyllis Zee, MD, Associate Director, Center for Sleep & Circadian Biology, discusses the relationship between circadian disruption and metabolic disease.

In this video, Denise Sharon, MD, PhD, Clinical Director and Founding Partner, Comprehensive Sleep Medicine Center of the Gulf Coast, discusses how insurers have responded to the availability of therapies and changes in clinical practice guidelines for RLS.

In a session on the neurobiology of sleep loss in humans, Andrea Spaeth, Daniel Aeschbach, PhD, and Clare Anderson, PhD, presented findings about the effects of sleep deprivation on various biological measures in humans.

In this video, James Horne, PhD, Director, Sleep Research Centre, provides his opinion on the relationship between lack of sleep and obesity.

In this presentation, Dr. Van Dongen discussed the pharmacology of various treatments for sleep disturbance associated with shift work. Dr. Van Dongen discussed the issues associated with use of medications to improve the alertness of sleepy workers.

In this video, Jennifer Martin, PhD, Assistant Professor, UCLA, David School of Medicine, discusses how the effectiveness of cognitive behavioral treatment for insomnia among patients with dementia compare with current pharmacologic strategies.

The electroencephalogram (EEG) provides important information to aid clinicians in the diagnosis of epilepsy. However, EEG techniques are associated with certain limitations, as discussed in the presentation by Bradley V. Vaughn, MD.

In this video, Jennifer Martin, PhD, Assistant Professor, UCLA, David School of Medicine, shares her thoughts on how non-pharmacologic treatments for the management of insomnia has evolved over the past few years and how the increased use of behavioral treatments might affect insurance coverage.

Sleep disorders are common in patients with epilepsy; approximately 70% of patients with epilepsy experience problems with sleep. In his presentation, Dr Erik St. Louis discussed the impact of sleep on seizures, as well as the effects of comorbid sleep disorders on epilepsy.

In his presentation, Gary H. Gibbons, MD, director of the National Heart, Lung, and Blood Institute at the National Institutes of Health, described the functions of his organization and discussed the potential for improvements in the understanding of disease states in the digital age.

In this video, Thomas Roth, PhD, Professor, Department of Psychiatry, Wayne State University School of Medicine, provides his opinion on the most important advance in our understanding of insomnia pathology in recent years.

The hospitalization risks and costs of positive airway pressure were evaluated among patients with obstructive sleep apnea in a real-world setting.